Abstract
Retinal injury and retinal degenerative diseases are a leading causes of visual impairment in the developed world. Mitochondrial dysfunction and oxidative stress play key roles in the pathogenesis of retinal injury and disease. The development and testing of strategies designed to improve mitochondrial function and attenuate oxidative stress are essential for combating retinal disease. One strategy involves the use of photobiomodulation. Photobiomodulation, low-energy photon irradiation by light in the far-red to near-infrared (NIR) range using low energy lasers or light-emitting diode (LED) arrays, has been applied clinically in the treatment soft tissue injuries and acceleration of wound healing for more than 30 years. The therapeutic effects of photobiomodulation have been hypothesized to be mediated by intracellular signaling mechanisms triggered by the interaction of farred to NIR photons with the mitochondrial photoacceptor molecule cytochrome oxidase which culminate in improved mitochondrial energy metabolism, increased synthesis of cytoprotective factors and cell survival.
The therapeutic potential of 670 nm LED photobiomodulation administered once per day at a fluence of 4 J/cm2 was investigated in established experimental models of retinal injury, retinal toxicity and retinal disease. Photobiomodulation stimulated retinal wound healing following high-intensity laser-induced retinal injury. Photobiomodulation not only enhanced the rate of wound healing, it also prevented the loss of retinal and cortical visual function induced by laser-induced retinal injury. In a rodent model of retinal mitochondrial toxicity, photobiomodulation preserved retinal function and prevented photoreceptor damage. Moreover, molecular studies revealed that photobiomodulation induced significant upregulation of gene expression pathways involved in mitochondrial energy production and cytoprotection in the retina. Retinitis pigmentosa is the leading cause of vision loss due to retinal degeneration. Photobiomodulation administered during the critical period of photoreceptor development in a rat model of retinitis pigmentosa increased retinal mitochondrial cytochrome oxidase activity, upregulated the production of retinal antioxidants, increased the production of retinal neurotrophic factors and prevented photoreceptor cell death.
The molecular, biochemical and functional insights obtained from this research provide crucial information needed for a comprehensive FDA approval for the use of photobiomodulation in the treatment of retinal diseases. From a basic science perspective, they substantiate previous in vitro investigations and support the hypothesis that photobiomodulation augments mitochondrial function and stimulates cytoprotective pathways to prevent retinal damage. From a clinical perspective, they document the therapeutic potential of 670 nm photon therapy in experimental models of retinal injury, retinal toxicity and retinitis pigmentosa, thus setting the stage for clinical trials of photobiomodulation in human disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hafezi, F. et al., Molecular Ophthalmology: an update on animal models for retinal degenerations and dystrophies. Br J Ophthalmol, 2000 84: 922–927.
Kanwar, M. et al., Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
Ranchon, I. et al., Free radical spin trap SPBN protects against light damage but does not rescue P23H and S334ter rhodopsin transgenic rats from inherited retinal degeneration. J Neurosci, 2003 23: 6050–6057.
Liang, H.L. et al., Photobiomodulation partially rescues visual cortical neurons from cyanide-induced apoptosis. Neuroscience, 2006 139(2): 639–649.
Desmet, K.D. et al., Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg, 2006 24(2): 121–128.
Wong-Riley, M.T. et al., Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J Biol Chem, 2005 280(6): 4761–4771.
Eells, J. et al., Therapeutic photobiomodulation for methanol-induced retinal toxicity. PNAS, 2003 100(6).
Stone, J. et al., Mechanisms of photoreceptor death and survival in mammalian retina. Prog Ret Eye Res, 1999 18: 689–735.
Sieving, P. et al., Ciliary neurotropic factor (CNTF) for human retinal degeneration: phase 1 trial of CNTF delivered by encapsulated cell intraocular implants. PNAS, 2006 103: 3896– 3901.
Gargini, C. et al., Electroretinogram changes associated with retinal upregulation of trophic factors: observations following optic nerve section. Neuroscience, 2004 126(3): 775–783.
Valter, K. et al., Time course of neurotrophic factor upregulation and retinal protection against light-induced damage after optic nerve section. Invest Ophthalmol Vis Sci, 2005 46 (5): 1748–1754.
Eells, J.T. et al., Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion, 2004 4(5–6): 559–567.
Karu, T., Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B, 1999 49: 1–17.
Eells, J. et al., Near-infrared light therapy for retinitis pigmentosa. Invest Ophthalmol Vis Sci, 2006: 47. ARVO Abstract 1022.
Geller, S. et al., Toxicity of hyperoxia to the retina: evidence from the mouse, in Retinal Degenerative Disease, J. Hollyfield, G. Anderson, and M. LaVail, Editors. 2005, Springer: Berlin/Heidelberg. pp. 425–438.
Algvere, P.V., J. Marshall, and S. Seregard, Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand, 2006 84(1): 4–15.
Komeima, K. et al., Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci USA, 2006 103(30): 11300–11305.
Wellard, J. et al., Photoreceptors in the rat retina are specifically vulnerable to both hypoxia and hyperoxia. Vis Neurosci, 2005 22(4): 501–507.
Yu, D. et al., Photoreceptor death, trophic factor expression, retinal oxygen status, and photoreceptor function in the P23H rat. Invest Ophthalmol Vis Sci, 2004 45(6).
Valter, K. et al., Photoreceptor dystrophy in the RCS rat: roles of oxygen, debris and bFGF. Invest Ophthal Vis Sci, 1998 39: 2427–2442.
Nixon, P.J. et al., The contribution of cone responses to rat electroretinograms. Clin Exp Ophthalmol, 2001 29(3): 193–196.
Stone, J., et al., Photoreceptor stability and degeneration in mammalian retina: lessons from the edge, in Macular Degeneration: Science and Medicine in Practice, P. Penfold and J. Provis, Editors. 2005, Springer Verlag. pp. 149–165.
Bravo-Nuevo, A. et al., Mitochondrial deletions in normal and degenerating rat retina, in Retinal Degenerations: Mechanisms and Experimental Therapy, M. La Vail, J. Hollyfield, and G. Anderson, Editors. 2003, Kluwer/Plenum: New York. pp. 241–248.
Qi, X. et al., Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem, 2006.
Shen, J. et al., Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa. J Cell Physiol, 2005 203: 457–464.
Maslim, J. et al., Tissue oxygen during a critical developmental period controls the death and survival of photoreceptors. Invest Ophthal Vis Sci, 1997 38: 1667–1677.
Machida, S. et al., P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci, 2000 41(10): 3200–3209.
Campian, J.L. et al., Oxygen tolerance and coupling of mitochondrial electron transport. J Biol Chem, 2004 279(45): 46580–46587.
Villani, G. et al., Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types. J Biol Chem, 1998 273(48): 31829–31836.
Schuschereba ST, Cross MT, Pizarro JM, et al., Pretreatment with hydroxyethyl starch-deferoxamine but not methylprednisolone reduces secondary injury to retina after laser irradiation. Lasers Light, 1997 8: 1–14.
Whelan, HT, Wong-Riley, MTT, Eells, JT, VerHoeve, JN, Das, R, Jett, M., DARPA soldier self care: rapid healing of laser eye injuries with light-emitting diode technology. NATO RTO-MP-HFM, 2005 109: 1–18.
Acknowledgments
We gratefully acknowledge the technical support of Quantum Devices, Inc. for providing the light emitting diode arrays for this project and Anna Fekete for excellent technical assistance. This work was supported by Defense Advanced Research Projects Agency Grant DARPA N66001-01-1-8969 (H.T.W.), National Institute of Environmental Health Sciences Grant ES06648 (J.T.E), National Eye Institute Core Grant P30-EY01931 (J.T.E. and M.W. R., Core Investigators), National Eye Institute Grantand EY05439 (M.W.R.), the Bleser Foundation Endowed Professorship (H.T.W.), An Individual Investigator Grant TA-NE-0606-0348-UWI from the Foundation Fighting Blindness (J.T.E.) and the ARC Center for Excellence in Vision Research (K.V., J.S).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this paper
Cite this paper
Eells, J.T. et al. (2008). Photobiomodulation for the Treatment of Retinal Injury and Retinal Degenerative Diseases. In: Waynant, R., Tata, D.B. (eds) Proceedings of Light-Activated Tissue Regeneration and Therapy Conference. Lecture Notes in Electrical Engineering, vol 12. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-71809-5_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-71809-5_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-71808-8
Online ISBN: 978-0-387-71809-5
eBook Packages: EngineeringEngineering (R0)